Ruffena Capital is the famous VC, which was founded in 2013. The venture was found in Europe in United Kingdom. The main department of described VC is located in the London.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Ruffena Capital, startups are often financed by Midven, Innovate UK, SevenMile Capital Partners. The meaningful sponsors for the fund in investment in the same round are SyndicateRoom, Seventure Partners, Oxford Technology Management. In the next rounds fund is usually obtained by Horizon 2020, EASME - EU Executive Agency for SMEs, Permira Debt Managers.
The overall number of key employees were 7.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The important activity for fund was in 2016. The top amount of exits for fund were in 2017. The fund is generally included in less than 2 deals every year. This Ruffena Capital works on 14 percentage points more the average amount of lead investments comparing to the other organizations.
We can highlight the next thriving fund investment areas, such as SaaS, Analytics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Cambrooke Therapeutics, Lightpoint Medical, appScatter. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom.
Related Funds
Fund Name | Location |
4S Bay Partners | Highland Park, Illinois, United States |
AKN Technology Bhd | Norway, Ostfold, Viken |
Awa Paper & Technological Company | Japan, Tokushima, Tokushima Prefecture |
Hillside Capital | New York, New York, United States |
Juntan Investment | - |
Lassonde | Canada, Quebec, Rougemont |
Mayi Tianshi | Changning, China, Shanghai |
MentorTech Ventures | Pennsylvania, Philadelphia, United States |
Taiyou Chuangtou | China, Zhejiang, Zhuji |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Cambrooke Therapeutics | 11 Apr 2016 | Massachusetts, United States | |||
Fantoo | $685K | 01 May 2015 | United Kingdom, England, United Kingdom | ||
Lightpoint Medical | $1M | 30 Dec 2014 | United Kingdom, England | ||
MSP Technologies | $685K | 12 Aug 2014 | United Kingdom, England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Cambrooke Therapeutics | 11 Apr 2016 | Massachusetts, United States | |||
Fantoo | $685K | 01 May 2015 | United Kingdom, England, United Kingdom | ||
Lightpoint Medical | $1M | 30 Dec 2014 | United Kingdom, England | ||
MSP Technologies | $685K | 12 Aug 2014 | United Kingdom, England |